Explore how computational software and AI are accelerating drug discovery, from virtual screening to molecular dynamics, with real-world examples like COVID-19 antivirals.
Explore the evolution of chemogenomics from target-centric drug discovery to AI-driven network medicine and virtual patient models.
Discover how row-constrained supersaturated designs and Lasso regression are revolutionizing high-throughput drug screening to combat antibiotic resistance.